
Biotechnology Development
Micropoint biotechnology R&D leverages strong collaboration with groups of researchers and scientists around the world to develop novel biomarkers and antibodies that are customized to meet the rapid diagnostic needs. These co-development programs encompass sets/libraries of bio-marker screening, cell line engineering, protein expression, and bio-processing.
Micropoint works with its partners to develop novel bio-markers and antibodies with high affinity and high specificity in each of the following stages:
-
Hybridoma development
-
Polyclonal antibody
-
Antibody purification
-
Antibody Fragmentation and isotyping
-
Conjugation and labeling
-
Immune response testing
-
Novel assay development
-
Bio-signal amplifications